Literature DB >> 35070138

Study of Cell Viability and Etiology of Contamination in Decalcified Bone Allograft: A Pilot Study.

Archit Jain1, Saurabh Kumar1, Vinod Kumar Arora2, Rumpa Saha3, Aditya N Aggarwal1, Anil Kumar Jain1.   

Abstract

BACKGROUND: Bone allografts can elicit immune responses which is correlated with the presence of Human Leukocyte Antigen (HLA) and cellular DNA. It also has risk of causing occult infection arising out of contamination during its processing and storage. The presence of immunogenic materials like cells, cellular remnants and DNA in a decalcified bone allograft during different phases of processing has never been studied. Present study was conducted to explore- the cell viability using routine Hematoxylin and Eosin, presence of DNA using Feulgen staining and etiology of contamination in decalcified bone allograft during procurement, demineralization and ethanol preservation.
METHODS: The harvested bones from patients undergoing hemireplacement/THR/TKR were processed to prepare decalcified bone allografts. The samples during procurement (A), HCL treatment (B) and ethanol preservation (C) were sent for histopathological analysis (number of osteocytes in the maximum density field under 40x and the cells demonstrating presence of DNA on feulgen stain) and microbiological assessment (aerobic/anaerobic/fungal cultures).
RESULTS: Histopathological study demonstrated the presence of osteocytes and other cells like bone marrow, adipocytes, endothelial cells in the decal bone allograft. The average number of osteocytes gradually decreased from 55.47, 9.6, 0.86 in sample A, B, C, respectively. Feulgen staining confirmed the presence of DNA in osteocytes and other cells which decreased both qualitatively and quantitatively in subsequent stages of processing. Rate of contamination demonstrated at the procurement was 6.67% (Staphylococcus aureus). After treatment with HCl (demineralisation), 7.14% of non-contaminated allografts were found contaminated (Staphylococcus epidermidis). None of the remaining 13 non-contaminated allografts showed contamination after storage in ethanol. Overall 13% of the patients had positive cultures on microbiological assessment.
CONCLUSION: The population of osteocytes in the harvested bone reduced significantly after processing with HCl and ethanol preservation. Presence of DNA, demonstrated by using Feulgen staining, was observed in bone marrow cells, adipocytes along with osteocytes which showed quantitative reduction on processing. Hence, antigenicity, conferred by cells and their DNA, reduced significantly after processing of decal bone. Contamination rate of banked decalcified allograft was 13%. Thus, culture and sensitivity tests should be carried out at each step of processing of decal bone allograft. © Indian Orthopaedics Association 2021.

Entities:  

Keywords:  Allograft; Bone bank; Bone morphogenic protein; Contamination; Decal bone; Feulgen staining

Year:  2021        PMID: 35070138      PMCID: PMC8748563          DOI: 10.1007/s43465-021-00410-9

Source DB:  PubMed          Journal:  Indian J Orthop        ISSN: 0019-5413            Impact factor:   1.033


  34 in total

1.  The bacteriology of bone allografts.

Authors:  P G Chapman; R N Villar
Journal:  J Bone Joint Surg Br       Date:  1992-05

2.  Bone banking. A cost effective method for establishing a community hospital bone bank.

Authors:  M M Hart; E D Campbell; M G Kartub
Journal:  Clin Orthop Relat Res       Date:  1986-05       Impact factor: 4.176

3.  Microbial contamination of femoral head allografts.

Authors:  C K Chiu; P Y Lau; S W W Chan; C M Fong; L K Sun
Journal:  Hong Kong Med J       Date:  2004-12       Impact factor: 2.227

4.  Infection in bone allografts. Incidence, nature, and treatment.

Authors:  C F Lord; M C Gebhardt; W W Tomford; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1988-03       Impact factor: 5.284

5.  Detection of living cells in non-processed but deep-frozen bone allografts.

Authors:  Ide C Heyligers; Jenneke Klein-Nulend
Journal:  Cell Tissue Bank       Date:  2005       Impact factor: 1.522

6.  Induction of specific T-cell responsiveness to allogeneic bone.

Authors:  M C Horowitz; G E Friedlaender
Journal:  J Bone Joint Surg Am       Date:  1991-09       Impact factor: 5.284

7.  Morbidity at bone graft donor sites.

Authors:  E M Younger; M W Chapman
Journal:  J Orthop Trauma       Date:  1989       Impact factor: 2.512

8.  Allogenic decalbone in the repair of benign cystic lesions of bone.

Authors:  S C Goel; S M Tuli; H P Singh; S V Sharma; S K Saraf; T P Srivastava
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

9.  Femoral head allograft bone banking.

Authors:  A D Saies; D C Davidson
Journal:  Aust N Z J Surg       Date:  1990-04

10.  Decalcified allograft in repair of lytic lesions of bone: A study to evolve bone bank in developing countries.

Authors:  Anil Kumar Gupta; Kumar Keshav; Praganesh Kumar
Journal:  Indian J Orthop       Date:  2016 Jul-Aug       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.